This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978;27(8):1221-7.

doi: 10.1016/0006-2952(78)90455-0.

Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells

PMID: 567991
DOI: 10.1016/0006-2952(78)90455-0

Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells

T Skovsgaard. Biochem Pharmacol. 1978.

. 1978;27(8):1221-7.

doi: 10.1016/0006-2952(78)90455-0.

Author

PMID: 567991
DOI: 10.1016/0006-2952(78)90455-0

No abstract available

PubMed Disclaimer

Similar articles

Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.
Skovsgaard T. Skovsgaard T. Biochem Pharmacol. 1977 Feb 1;26(3):215-22. doi: 10.1016/0006-2952(77)90306-9. Biochem Pharmacol. 1977. PMID: 14644 No abstract available.
Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells.
Skovsgaard T. Skovsgaard T. Cancer Res. 1978 Jun;38(6):1785-91. Cancer Res. 1978. PMID: 647687 No abstract available.
Calcium modifies the accumulation and retention of daunorubicin by Ehrlich ascites carcinoma.
Murray SL, Du Vall EM, Slater LM. Murray SL, et al. Cancer Chemother Pharmacol. 1984;13(1):69-70. doi: 10.1007/BF00401452. Cancer Chemother Pharmacol. 1984. PMID: 6733845
Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivo.
Skovsgaard T. Skovsgaard T. Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):301-8. Cancer Chemother Rep. 1975. PMID: 1149008
Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.
Dano K. Dano K. Biochim Biophys Acta. 1973 Oct 25;323(3):466-83. doi: 10.1016/0005-2736(73)90191-0. Biochim Biophys Acta. 1973. PMID: 4796512 No abstract available.

See all similar articles

Cited by

Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
Coley HM, Twentyman PR, Workman P. Coley HM, et al. Cancer Chemother Pharmacol. 1989;24(5):284-90. doi: 10.1007/BF00304759. Cancer Chemother Pharmacol. 1989. PMID: 2547527
A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids.
West CM, Stratford IJ. West CM, et al. Cancer Chemother Pharmacol. 1987;20(2):109-14. doi: 10.1007/BF00253963. Cancer Chemother Pharmacol. 1987. PMID: 2822273
Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.
Friche E, Skovsgaard T, Nissen NI. Friche E, et al. Cancer Chemother Pharmacol. 1987;19(1):35-9. doi: 10.1007/BF00296252. Cancer Chemother Pharmacol. 1987. PMID: 3815723
A short-term in vitro test for tumour sensitivity to adriamycin based on flow cytometric DNA analysis.
Engelholm SA, Spang-Thomsen M, Vindeløv LL. Engelholm SA, et al. Br J Cancer. 1983 Apr;47(4):497-502. doi: 10.1038/bjc.1983.79. Br J Cancer. 1983. PMID: 6849794 Free PMC article.
Detection of drug resistance in human ovarian carcinoma.
Volm M, Efferth T, Bak M, Mattern J. Volm M, et al. Arch Gynecol Obstet. 1989;244(2):123-8. doi: 10.1007/BF00931383. Arch Gynecol Obstet. 1989. PMID: 2653233

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science